NEW YORK, Aug. 27 (Xinhua) -- U.S. drug-maker Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials, in addition to standard injection-pen devices, at about half the price of the original for certain doses, The Wall Street Journal reported Tuesday.
To date, Zepbound has been packaged in a single device, an injection pen that contains both the drug and the needle. Patients press a button on one end to insert a needle on the other end that delivers the dose. With the new vials, patients will use a syringe to draw out their dose and then to inject themselves.
